1-11 of 11
Rana R. McKay
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Structurally Oriented Classification of FOXA1 Alterations Identifies Prostate Cancers with Opposing Clinical Outcomes and Distinct Molecular and Immunologic Subtypes

Justin Hwang, Pornlada Likasitwatanakul, Sachin Kumar Deshmukh, Sharon Wu, Jason J. Kwon, Eamon Toye, David Moline, Mark G. Evans, Andrew Elliott, Rachel Passow, Christine Luo, Emily John, Nishant Gandhi, Rana R. McKay, Elisabeth I. Heath, Chadi Nabhan, Natalie Reizine, Jacob J. Orme, Josep M. Domingo Domenech, Oliver Sartor, Sylvan C. Baca, Scott M. Dehm, Emmanuel S. Antonarakis
Journal: Clinical Cancer Research
Clin Cancer Res OF1–OF13.
https://doi.org/10.1158/1078-0432.CCR-24-3471
Published: 30 January 2025
View article titled, Structurally Oriented Classification of <em>FOXA1</em> Alterations Identifies Prostate Cancers with Opposing Clinical Outcomes and Distinct Molecular and Immunologic Subtypes
Open the PDF for Structurally Oriented Classification of <em>FOXA1</em> Alterations Identifies Prostate Cancers with Opposing Clinical Outcomes and Distinct Molecular and Immunologic Subtypes in another window
Includes: Supplementary data
Journal Articles

Abstract B041: High purity CTC RNA sequencing identifies poor prognosis lineage states in castrate resistant prostate cancer

Marina N Sharifi, Jamie M Sperger, Amy K Taylor, Katharine E Tippins, Shannon R Reese, Viridiana Carreno, Katherine R Kaufmann, Alex H Chang, Luke A Nunamaker, Charlotte Linebarger, Kyle T Helzer, Matthew Bootsma, Grace C Blitzer, John Floberg, David Kosoff, Rana R McKay, Xiao X Wei, Shuang G Zhao, Joshua M Lang
Journal: Clinical Cancer Research
Clin Cancer Res (2024) 30 (21_Supplement): B041.
https://doi.org/10.1158/1557-3265.LIQBIOP24-B041
Published: 13 November 2024
View article titled, Abstract B041: High purity CTC RNA sequencing identifies poor prognosis lineage states in castrate resistant prostate cancer
Journal Articles

Abstract PR010: High purity CTC RNA sequencing identifies poor prognosis lineage states in castrate resistant prostate cancer

Marina N Sharifi, Jamie M Sperger, Amy K Taylor, Katharine E Tippins, Shannon R Reese, Viridiana Carreno, Katherine R Kaufmann, Alex H Chang, Luke A Nunamaker, Charlotte Linebarger, Kyle T Helzer, Matthew Bootsma, Grace C Blitzer, John Floberg, David Kosoff, Rana R McKay, Xiao X Wei, Shuang G Zhao, Joshua M Lang
Journal: Clinical Cancer Research
Clin Cancer Res (2024) 30 (21_Supplement): PR010.
https://doi.org/10.1158/1557-3265.LIQBIOP24-PR010
Published: 13 November 2024
View article titled, Abstract PR010: High purity CTC RNA sequencing identifies poor prognosis lineage states in castrate resistant prostate cancer
Journal Articles

Evaluating Immune Checkpoint Blockade in Metastatic Castration-Resistant Prostate Cancers with Deleterious CDK12 Alterations in the Phase 2 IMPACT Trial

Charles B. Nguyen, Melissa A. Reimers, Chamila Perera, Wassim Abida, Jonathan Chou, Felix Y. Feng, Emmanuel S. Antonarakis, Rana R. McKay, Russell K. Pachynski, Jingsong Zhang, Zachery R. Reichert, Phillip L. Palmbos, Megan E.V. Caram, Ulka N. Vaishampayan, Elisabeth I. Heath, Alexander C. Hopkins, Marcin P. Cieslik, Yi-Mi Wu, Dan R. Robinson, Veerabhadran Baladandayuthapani, Arul M. Chinnaiyan, Ajjai S. Alva
Journal: Clinical Cancer Research
Clin Cancer Res (2024) 30 (15): 3200–3210.
https://doi.org/10.1158/1078-0432.CCR-24-0400
Published: 01 August 2024
View article titled, Evaluating Immune Checkpoint Blockade in Metastatic Castration-Resistant Prostate Cancers with Deleterious <em>CDK12</em> Alterations in the Phase 2 IMPACT Trial
Open the PDF for Evaluating Immune Checkpoint Blockade in Metastatic Castration-Resistant Prostate Cancers with Deleterious <em>CDK12</em> Alterations in the Phase 2 IMPACT Trial in another window
Includes: Supplementary data
Journal Articles

Metastatic Prostate Cancers with BRCA2 versus ATM Mutations Exhibit Divergent Molecular Features and Clinical Outcomes

Justin Hwang, Xiaolei Shi, Andrew Elliott, Taylor E. Arnoff, Julie McGrath, Joanne Xiu, Phillip Walker, Hannah E. Bergom, Abderrahman Day, Shihab Ahmed, Sydney Tape, Allison Makovec, Atef Ali, Rami M. Shaker, Eamon Toye, Rachel Passow, John R. Lozada, Jinhua Wang, Emil Lou, Kent W. Mouw, Benedito A. Carneiro, Elisabeth I. Heath, Rana R. McKay, W. Michael Korn, Chadi Nabhan, Charles J. Ryan, Emmanuel S. Antonarakis
Journal: Clinical Cancer Research
Clin Cancer Res (2023) 29 (14): 2702–2713.
https://doi.org/10.1158/1078-0432.CCR-22-3394
Published: 14 July 2023
View article titled, Metastatic Prostate Cancers with <em>BRCA2</em> versus <em>ATM</em> Mutations Exhibit Divergent Molecular Features and Clinical Outcomes
Open the PDF for Metastatic Prostate Cancers with <em>BRCA2</em> versus <em>ATM</em> Mutations Exhibit Divergent Molecular Features and Clinical Outcomes in another window
Includes: Supplementary data
Journal Articles

Phase II Multicenter Study of Enzalutamide in Metastatic Castration-Resistant Prostate Cancer to Identify Mechanisms Driving Resistance

Rana R. McKay, Lucia Kwak, Jett P. Crowdis, Jamie M. Sperger, Shuang G. Zhao, Wanling Xie, Lillian Werner, Rosina T. Lis, Zhenwei Zhang, Xiao X. Wei, Joshua M. Lang, Eliezer M. Van Allen, Rupal S. Bhatt, Evan Y. Yu, Peter S. Nelson, Glenn J. Bubley, R. Bruce Montgomery, Mary-Ellen Taplin
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (13): 3610–3619.
https://doi.org/10.1158/1078-0432.CCR-20-4616
Published: 01 July 2021
View article titled, Phase II Multicenter Study of Enzalutamide in Metastatic Castration-Resistant Prostate Cancer to Identify Mechanisms Driving Resistance
Open the PDF for Phase II Multicenter Study of Enzalutamide in Metastatic Castration-Resistant Prostate Cancer to Identify Mechanisms Driving Resistance in another window
Includes: Supplementary data
Journal Articles

Abstract S09-04: Asymptomatic detection of COVID-19 among cancer patients receiving infusional anti-cancer therapy

Justin A. Shaya, Angelo Cabal, Francesca Torriani, Joseph Califano, Scott Lippman, Assuntina Sacco, Rana R. McKay
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (6_Supplement): S09-04.
https://doi.org/10.1158/1557-3265.COVID-19-21-S09-04
Published: 15 March 2021
View article titled, Abstract S09-04: Asymptomatic detection of COVID-19 among cancer patients receiving infusional anti-cancer therapy
Journal Articles

Abstract P30: Long-term outcomes of cancer patients infected with COVID-19

Justin Shaya, Angelo Cabal, Pedram Razavi, Rana R. McKay
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (6_Supplement): P30.
https://doi.org/10.1158/1557-3265.COVID-19-21-P30
Published: 15 March 2021
View article titled, Abstract P30: Long-term outcomes of cancer patients infected with COVID-19
Journal Articles

Radium-223 Dichloride in Combination with Vascular Endothelial Growth Factor–Targeting Therapy in Advanced Renal Cell Carcinoma with Bone Metastases

Rana R. McKay, Dominick Bossé, Kathryn P. Gray, M. Dror Michaelson, Katherine Krajewski, Heather A. Jacene, Meghara Walsh, Joaquim Bellmunt, Mark Pomerantz, Lauren C. Harshman, Toni K. Choueiri
Journal: Clinical Cancer Research
Clin Cancer Res (2018) 24 (17): 4081–4088.
https://doi.org/10.1158/1078-0432.CCR-17-3577
Published: 04 September 2018
View article titled, Radium-223 Dichloride in Combination with Vascular Endothelial Growth Factor–Targeting Therapy in Advanced Renal Cell Carcinoma with Bone Metastases
Open the PDF for Radium-223 Dichloride in Combination with Vascular Endothelial Growth Factor–Targeting Therapy in Advanced Renal Cell Carcinoma with Bone Metastases in another window
Includes: Supplementary data
Journal Articles

A Phase II Trial of Abiraterone Combined with Dutasteride for Men with Metastatic Castration-Resistant Prostate Cancer

Rana R. McKay, Lillian Werner, Elahe A. Mostaghel, Rosina Lis, Olga Voznesensky, Zhenwei Zhang, Brett T. Marck, Alvin M. Matsumoto, Liran Domachevsky, Katherine A. Zukotynski, Manoj Bhasin, Glenn J. Bubley, Bruce Montgomery, Philip W. Kantoff, Steven P. Balk, Mary-Ellen Taplin
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (4): 935–945.
https://doi.org/10.1158/1078-0432.CCR-16-0987
Published: 14 February 2017
View article titled, A Phase II Trial of Abiraterone Combined with Dutasteride for Men with Metastatic Castration-Resistant Prostate Cancer
Open the PDF for A Phase II Trial of Abiraterone Combined with Dutasteride for Men with Metastatic Castration-Resistant Prostate Cancer in another window
Includes: Supplementary data
Journal Articles

Angiotensin System Inhibitors and Survival Outcomes in Patients with Metastatic Renal Cell Carcinoma

Rana R. McKay, Gustavo E. Rodriguez, Xun Lin, Marina D. Kaymakcalan, Ole-Petter R. Hamnvik, Venkata S. Sabbisetti, Rupal S. Bhatt, Ronit Simantov, Toni K. Choueiri
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (11): 2471–2479.
https://doi.org/10.1158/1078-0432.CCR-14-2332
Published: 31 May 2015
View article titled, Angiotensin System Inhibitors and Survival Outcomes in Patients with Metastatic Renal Cell Carcinoma
Open the PDF for Angiotensin System Inhibitors and Survival Outcomes in Patients with Metastatic Renal Cell Carcinoma in another window